197 related articles for article (PubMed ID: 38275044)
1. Recent Advancement in Inhaled Nano-drug Delivery for Pulmonary, Nasal, and Nose-to-brain Diseases.
Fu Q; Liu Y; Peng C; Muluh TA; Anayyat U; Liang L
Curr Drug Deliv; 2024 Jan; ():. PubMed ID: 38275044
[TBL] [Abstract][Full Text] [Related]
2. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors.
Jeong SH; Jang JH; Lee YB
J Pharm Investig; 2023; 53(1):119-152. PubMed ID: 35910081
[TBL] [Abstract][Full Text] [Related]
4. Nasal delivery of neurotherapeutics
Rajput A; Pingale P; Dhapte-Pawar V
Front Pharmacol; 2022; 13():979682. PubMed ID: 36176429
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of drug delivery to the brain via nasal route.
Kozlovskaya L; Abou-Kaoud M; Stepensky D
J Control Release; 2014 Sep; 189():133-40. PubMed ID: 24997277
[TBL] [Abstract][Full Text] [Related]
6. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action.
Henkin RI
Nutrition; 2010 Jan; 26(1):33-9. PubMed ID: 20005465
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology-based Nose-to-brain Delivery in Epilepsy: A Novel Approach to Diagnosis and Treatment.
Khan J; Yadav S
Pharm Nanotechnol; 2023 Oct; ():. PubMed ID: 37818558
[TBL] [Abstract][Full Text] [Related]
8. Research progress in brain-targeted nasal drug delivery.
Huang Q; Chen X; Yu S; Gong G; Shu H
Front Aging Neurosci; 2023; 15():1341295. PubMed ID: 38298925
[TBL] [Abstract][Full Text] [Related]
9. Natural Products-Based Inhaled Formulations for Treating Pulmonary Diseases.
Yong J; Shu H; Zhang X; Yang K; Luo G; Yu L; Li J; Huang H
Int J Nanomedicine; 2024; 19():1723-1748. PubMed ID: 38414528
[TBL] [Abstract][Full Text] [Related]
10. Nasal route and drug delivery systems.
Türker S; Onur E; Ozer Y
Pharm World Sci; 2004 Jun; 26(3):137-42. PubMed ID: 15230360
[TBL] [Abstract][Full Text] [Related]
11. Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy.
Jin Z; Gao Q; Wu K; Ouyang J; Guo W; Liang XJ
Adv Drug Deliv Rev; 2023 Nov; 202():115111. PubMed ID: 37820982
[TBL] [Abstract][Full Text] [Related]
12. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.
Phukan K; Nandy M; Sharma RB; Sharma HK
Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366
[TBL] [Abstract][Full Text] [Related]
13. Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting.
Sonvico F; Clementino A; Buttini F; Colombo G; Pescina S; Stanisçuaski Guterres S; Raffin Pohlmann A; Nicoli S
Pharmaceutics; 2018 Mar; 10(1):. PubMed ID: 29543755
[TBL] [Abstract][Full Text] [Related]
14. Numerical Comparison of Nasal Aerosol Administration Systems for Efficient Nose-to-Brain Drug Delivery.
Dong J; Shang Y; Inthavong K; Chan HK; Tu J
Pharm Res; 2017 Dec; 35(1):5. PubMed ID: 29288465
[TBL] [Abstract][Full Text] [Related]
15. Lipid Nanoparticles for Nasal/Intranasal Drug Delivery.
Cunha S; Amaral MH; Lobo JMS; Silva AC
Crit Rev Ther Drug Carrier Syst; 2017; 34(3):257-282. PubMed ID: 28845761
[TBL] [Abstract][Full Text] [Related]
16. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
Islam SU; Shehzad A; Ahmed MB; Lee YS
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326318
[TBL] [Abstract][Full Text] [Related]
17. Nanoemulsions for "Nose-to-Brain" Drug Delivery.
Bonferoni MC; Rossi S; Sandri G; Ferrari F; Gavini E; Rassu G; Giunchedi P
Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781585
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines.
Guo Y; Bera H; Shi C; Zhang L; Cun D; Yang M
Acta Pharm Sin B; 2021 Aug; 11(8):2565-2584. PubMed ID: 34522598
[TBL] [Abstract][Full Text] [Related]
19. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
Kanazawa T
Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications.
Kumar R; Mehta P; Shankar KR; Rajora MAK; Mishra YK; Mostafavi E; Kaushik A
Pharm Res; 2022 Nov; 39(11):2831-2855. PubMed ID: 35552983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
